The drug firm Torrent Pharmaceuticals announced a 27.04percent rise in consolidated net profit to Rs 310 crore for the quarter ended September mainly on account of robust sales in India and reduction in expenses.
India revenues at Rs 963 crores grew by 7% versus the IPM growth 1% for the quarter as per AIOCD.Torrent pharmaceuticals said in release.
Torrent Pharma is a specialty- focused company with 75% of its revenue in India from chronic and sub-chronic therapies.
Hypertension, or high blood pressure, has become a silent but deadly crisis in India. The…
Elon Musk's Neuralink has made groundbreaking strides in its mission to integrate brain-computer interface (BCI)…
Air pollution, a silent but pervasive environmental hazard, is increasingly impacting human health worldwide. Long-term…
Fake Medicine: Did you know that fake medicines can cause serious damage to your body's…
Surgical Site Infection: In India, the rate of infections after surgery is rapidly increasing. Surgical…
A recent study conducted by the Indian Council of Medical Research (ICMR) reveals concerning insights…